"Lamin Type A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of developmentally regulated lamins having a neutral isoelectric point. They are found to disassociate from nuclear membranes during mitosis.
Below are MeSH descriptors whose meaning is more general than "Lamin Type A".
Below are MeSH descriptors whose meaning is more specific than "Lamin Type A".
This graph shows the total number of publications written about "Lamin Type A" by people in Harvard Catalyst Profiles by year, and whether "Lamin Type A" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 5 | 1 | 6 |
| 2005 | 3 | 2 | 5 |
| 2006 | 3 | 4 | 7 |
| 2007 | 3 | 1 | 4 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 2 | 4 |
| 2010 | 2 | 1 | 3 |
| 2011 | 4 | 3 | 7 |
| 2012 | 3 | 3 | 6 |
| 2013 | 2 | 2 | 4 |
| 2014 | 3 | 5 | 8 |
| 2015 | 3 | 5 | 8 |
| 2016 | 4 | 3 | 7 |
| 2017 | 4 | 1 | 5 |
| 2018 | 2 | 5 | 7 |
| 2019 | 0 | 2 | 2 |
| 2020 | 2 | 2 | 4 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 10 | 10 |
| 2023 | 0 | 6 | 6 |
| 2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Lamin Type A" by people in Profiles.
-
Effect of sequential burr passes on minimally invasive akin and first metatarsal dorsiflexion osteotomies. Foot Ankle Surg. 2024 Apr; 30(3):258-262.
-
The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B. Nucleus. 2023 Dec; 14(1):2288476.
-
ATR promotes clearance of damaged DNA and damaged cells by rupturing micronuclei. Mol Cell. 2023 10 19; 83(20):3642-3658.e4.
-
LMNA Cardiomyopathy: Important Considerations for the Heart Failure Clinician. J Card Fail. 2023 Dec; 29(12):1657-1666.
-
Long-term effectiveness of ARRY-371797 in people with dilated cardiomyopathy and a faulty LMNA gene: a plain language summary. Future Cardiol. 2023 03; 19(3):117-126.
-
Lonafarnib improves cardiovascular function and survival in a mouse model of Hutchinson-Gilford progeria syndrome. Elife. 2023 03 17; 12.
-
Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation. Circulation. 2023 06 06; 147(23):1734-1744.
-
LMNA Mutations and Right Heart Failure in Patients With Cardiomyopathy and With Left Ventricular Assist Devices. J Card Fail. 2023 05; 29(5):855-857.
-
Plain Language Summary of Publication of the safety and efficacy of ARRY-371797 in people with dilated cardiomyopathy and a faulty LMNA gene. Future Cardiol. 2023 02; 19(2):55-63.
-
Intrinsic Atrial Myopathy Precedes Left Ventricular Dysfunction and Predicts Atrial Fibrillation in Lamin A/C Cardiomyopathy. Circ Genom Precis Med. 2023 02; 16(1):e003480.